194 related articles for article (PubMed ID: 18004082)
1. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
Dai N; Bao Q; Lu A; Li J
Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
4. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer].
Zhuge YH; Tao HQ; Wang YY
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2765-8. PubMed ID: 22322056
[TBL] [Abstract][Full Text] [Related]
8. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
Maehara Y; Tomoda M; Hasuda S; Kabashima A; Tokunaga E; Kakeji Y; Sugimachi K
Br J Cancer; 1999 Mar; 79(7-8):1255-61. PubMed ID: 10098768
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of tumor vascularity in gastric carcinoma].
Tao H; Lin Y; Yin H; Wang R
Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):307-9, 57. PubMed ID: 11825396
[TBL] [Abstract][Full Text] [Related]
12. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of hypoxia-inducible factor-1alpha in gastric cancer].
Han B; Xu RH; Shi YX; Li YH; Luo HY; Wang F; Hou JH; Cai MY; Jiang WQ
Ai Zheng; 2006 Nov; 25(11):1439-42. PubMed ID: 17094917
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of CXCL12 expression in gastric cancer.
Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of osteopontin in patients with triple-negative breast cancer.
Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
[TBL] [Abstract][Full Text] [Related]
17. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
18. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 expression in gastric cancer.
Tsutsumi S; Kuwano H; Nagashima N; Shimura T; Mochiki E; Asao T
Hepatogastroenterology; 2005; 52(62):654-6. PubMed ID: 15816498
[TBL] [Abstract][Full Text] [Related]
20. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]